Head-to-head · WeighScore
FormidableMD vs Harmon.Health
By GLP-1 ScorecardUpdated
Score comparison
Harmon.Health has the higher recorded score — 74/100 to 73.2/100, but only just.
Harmon.Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harmon.Health sells compounded semaglutide and tirzepatide at one price for every dose, plus dissolving tablets and the brand Wegovy pill, but its site links to no published terms. FormidableMD is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the FormidableMD review and the Harmon.Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, FormidableMD vs Healthicare and Harmon.Health vs LifeMD compare each of them with another graded program, and the list of alternatives to FormidableMD ranks the programs closest to FormidableMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | FormidableMD | Harmon.Health |
|---|---|---|
| WeighScore | 73.2/100 | 74/100 |
| Grade | C | C |
| Site position | #78 | #72 |
| Semaglutide | $169/mo (1 mg dose, compounded) | $149/mo (month-to-month; $389 billed quarterly or $1,249 yearly, same price at every dose, compounded) |
| Tirzepatide | $199/mo (10 mg dose, compounded) | $199/mo (month-to-month; $499 billed quarterly or $1,599 yearly, same price at every dose, compounded) |
| Coverage | 1 state | All states except Mississippi |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
- Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
- Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible
What to consider
- Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
- Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
- The 503A compounding pharmacy partner is not named on the site
Site position #72 · C
Strengths
- Same price at every dose, with quarterly and yearly plans
- Offers injections, dissolving tablets and the brand Wegovy pill
- Serves every state except Mississippi
What to consider
- The Terms of Service, telehealth consent and privacy notice links in the footer lead nowhere
- Neither the prescribing physicians nor the pharmacies are named
- Introductory prices run until December 1, 2026, and some prices depend on a separate club membership
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.